Woodline Partners’s Wave Life Sciences WVE Stock Holding History

Woodline Partners’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Hold	350,531	–	–	0.01%	839
2026 Q1	$2.54M	Hold	350,531	–	–	0.01%	776
2025 Q4	$5.96M	Buy	+350,531	New	+$3.56M	0.02%	588
2025 Q3	–	Sell	-452,060	Closed	-$2.94M	–	1066
2025 Q2	$2.94M	Hold	452,060	–	–	0.02%	661
2025 Q1	$3.65M	Buy	452,060 +247	+0.1%	+$2.7K	0.02%	574
2024 Q4	$5.59M	Hold	451,813	–	–	0.04%	465
2024 Q3	$3.7M	Buy	+451,813	New	+$2.7M	0.03%	425
2024 Q2	–	Sell	-948,444	Closed	-$5.85M	–	690
2024 Q1	$5.85M	Sell	948,444 -443,117	-32%	-$2.22M	0.05%	343
2023 Q4	$7.03M	Buy	1,391,561 +162,878	+13%	+$871K	0.08%	269
2023 Q3	$7.06M	Buy	+1,228,683	New	+$5.61M	0.08%	262
2023 Q2	–	Sell	-510,898	Closed	-$2.21M	–	765
2023 Q1	$2.21M	Buy	510,898 +161,414	+46%	+$740K	0.03%	404
2022 Q4	$2.45M	Sell	349,484 -137,730	-28%	-$635K	0.03%	452
2022 Q3	$1.76M	Buy	+487,214	New	+$1.61M	0.02%	482

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Woodline Partners's WVE Position: Q2 2026 in Review

Woodline Partners held its Wave Life Sciences (WVE) position steady in Q2 2026 at 350,531 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #839.

Woodline Partners first reported a position in WVE in Q3 2022 and has held it in 13 quarters since. The position peaked at $7.06M in Q3 2023. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Woodline Partners held 350,531 shares of Wave Life Sciences worth $2.04M as of Q2 2026.
Woodline Partners left its Wave Life Sciences share count unchanged in Q2 2026.
Wave Life Sciences made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #839 holding.
Woodline Partners first reported a position in Wave Life Sciences in Q3 2022 and has held it in 13 quarters since.
Woodline Partners's Wave Life Sciences position peaked at $7.06M in Q3 2023.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.